首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

数位PCR市场规模、份额和成长分析（按类型、产品类型、技术、适应症、应用、最终用户和地区划分）－产业预测（2026-2033年）

市场调查报告书

商品编码

1897843

数位PCR市场规模、份额和成长分析（按类型、产品类型、技术、适应症、应用、最终用户和地区划分）－产业预测（2026-2033年）

Digital PCR Market Size, Share, and Growth Analysis, By Type (Quantitative, Digital), By Product (Consumables & Reagents, Digital PCR Instruments), By Technology, By Indication, By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，数位 PCR 市场规模将达到 90.9 亿美元，到 2025 年将达到 99.5 亿美元，到 2033 年将达到 205.7 亿美元，在预测期（2026-2033 年）内，复合年增长率为 9.5%。

全球数位PCR市场正经历显着成长，这主要得益于对精准、灵敏的核酸定量和分析需求的不断增长。这项创新技术凭藉其无与伦比的准确性和灵敏度，在研究、疾病诊断和基因检测中发挥着至关重要的作用。该市场旨在为医疗专业人员和研究人员提供先进的分子诊断解决方案，以提供可靠的结果，从而改善患者照护并促进科学进步。市场的主要驱动因素包括感染疾病和遗传疾病发病率的上升、对个人化医疗日益增长的需求以及基因组研究的重大进展。儘管高成本和用户知识有限等挑战依然存在，但多重数位PCR检测和与次世代定序的整合等进步正在为数位PCR领域创造一个稳健且不断发展的环境。

数位PCR市场驱动因素

受医疗保健领域对精准诊断工具需求不断增长的推动，数位PCR市场正经历显着增长。随着精准医疗的日益普及，对高灵敏度和高特异性检测方法的需求也日益增长。数位PCR技术已被证明在临床诊断和研究中具有巨大优势，因为它能够准确检测基因突变、癌症生物标记和感染疾病。高品质的诊断在製定个人化治疗方案中发挥关键作用，进一步提升了对个人化治疗方法的需求。这种对更高诊断准确性的追求正在推动数位PCR市场的显着扩张。

数位PCR市场面临的限制因素

数位PCR市场面临许多挑战，主要在于所需设备和耗材成本高。小规模实验室，尤其是经济欠发达地区的实验室，可能难以承担技术和材料所需的投资。这种经济障碍限制了尖端诊断工具的普及，导致医疗机构采用率低。因此，许多医疗专业人员可能选择更经济实惠的传统PCR方法，而成本问题限制着创新技术的普及，最终可能阻碍整个数位PCR产业的成长和发展。

数位PCR市场趋势

数位PCR市场正经历一个显着的趋势，即机器学习（ML）和人工智慧（AI）技术的融合。这些技术的进步显着提升了数据处理能力，从而能够对复杂的基因数据进行精准分析。人工智慧演算法可以自动执行常规任务并优化实验设计，提高工作流程效率和生产力。此外，透过机器学习增强的预测建模有助于更深入地了解基因突变和疾病机制。这些技术的整合不仅加速了各领域先进诊断工具的开发，也拓展了数位PCR仪器的应用范围和实用性，从而推动了市场成长和创新。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Bio-Rad Laboratories, Inc.（USA）
Thermo Fisher Scientific Inc.（USA）
QIAGEN NV（Germany/Netherlands）
F. Hoffmann-La Roche AG（Switzerland）
Merck KGaA（Germany）
Danaher Corporation（USA）
Sysmex Corporation（Japan）
JN Medsys Pte. Ltd.（Singapore）
Stilla Technologies SAS（France）
Standard BioTools Inc.（USA）
Fluidigm Corporation（USA）
Avance Biosciences（USA）
Takara Bio Inc.（Japan）
Meridian Bioscience（USA）
Becton, Dickinson and Company（USA）
Abbott Laboratories（USA）
Promega Corporation（USA）
Endress+Hauser Group Services AG（Switzerland）
Biomerieux（France）
Eppendorf AG（Germany）

结论与建议

简介目录

Product Code: SQMIG35G2206

Digital PCR Market size was valued at USD 9.09 Billion in 2024 and is poised to grow from USD 9.95 Billion in 2025 to USD 20.57 Billion by 2033, growing at a CAGR of 9.5% during the forecast period (2026-2033).

The global digital PCR market is experiencing notable growth, driven by the increasing need for precise and sensitive nucleic acid quantification and analysis. This innovative technology is essential for research, disease diagnosis, and genetic testing owing to its unmatched accuracy and sensitivity. The market aims to deliver advanced molecular diagnostic solutions that empower healthcare professionals and researchers to achieve reliable results, ultimately enhancing patient care and fostering scientific advancements. Key market drivers include rising cases of infectious diseases and genetic disorders, a growing demand for personalized medicine, and significant advancements in genomic research. While challenges such as high costs and limited user knowledge persist, advancements like multiplex digital PCR assays and integration with next-generation sequencing are shaping a robust and evolving landscape in digital PCR.

Top-down and bottom-up approaches were used to estimate and validate the size of the Digital PCR market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Digital PCR Market Segments Analysis

Global Digital PCR Market is segmented by Type, Product, Technology, Indication, Application, End User and region. Based on Type, the market is segmented into Quantitative, Digital and End-point. Based on Product, the market is segmented into Consumables & Reagents, Digital PCR Instruments and Software & Services. Based on Technology, the market is segmented into Droplet Digital PCR, Chip-based Digital PCR and Others. Based on Indication, the market is segmented into Oncology, Infectious Disease, Genetic Disorders and Others. Based on Application, the market is segmented into Clinical Applications, Research Applications, Forensic Applications, Environmental Applications and Other Applications. Based on End User, the market is segmented into Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, CROs and CDMOs, Forensic Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Digital PCR Market

The digital PCR market is experiencing significant growth driven by the increasing need for precise diagnostic tools within the healthcare sector. As the focus shifts toward precision medicine, there is a rising demand for testing methods that offer high sensitivity and specificity. Digital PCR technology proves to be exceptionally beneficial for clinical diagnostics and research, enabling the accurate detection of genetic alterations, cancer biomarkers, and infectious diseases. Quality diagnostics play a crucial role in personalizing treatment plans, further enhancing the demand for tailored therapeutic approaches. This quest for greater diagnostic accuracy is propelling substantial expansion within the digital PCR market.

Restraints in the Digital PCR Market

The digital PCR market faces significant challenges primarily due to the high expenses associated with the necessary equipment and consumables. Smaller laboratories, especially in economically disadvantaged regions, may find the financial investment required for the technology and materials prohibitively expensive. This financial hurdle can limit access to cutting-edge diagnostic tools, leading to a slower adoption rate among healthcare providers. Consequently, many practitioners might choose to rely on more affordable traditional PCR methods, which could ultimately hinder the overall growth and advancement of the digital PCR industry, as the transition to innovative technologies remains constrained by cost-related issues.

Market Trends of the Digital PCR Market

The digital PCR market is experiencing a notable trend driven by the integration of machine learning (ML) and artificial intelligence (AI) technologies. These advancements significantly enhance data processing capabilities, allowing for accurate analysis of intricate genetic data. By automating routine tasks and optimizing experimental designs, AI algorithms improve workflow efficiency and productivity. Additionally, machine learning's ability to enhance predictive modeling fosters deeper insights into genetic variants and disease mechanisms. This convergence of technologies not only accelerates the development of sophisticated diagnostic tools across various sectors but also broadens the applicability and usability of digital PCR devices, propelling market growth and innovation.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis

Global Digital PCR Market Size by Type & CAGR (2026-2033)

Market Overview
Quantitative
Digital
End-point

Global Digital PCR Market Size by Product & CAGR (2026-2033)

Market Overview
Consumables & Reagents
Digital PCR Instruments
Software & Services

Global Digital PCR Market Size by Technology & CAGR (2026-2033)

Market Overview
Droplet Digital PCR
Chip-based Digital PCR
Others

Global Digital PCR Market Size by Indication & CAGR (2026-2033)

Market Overview
Oncology
Infectious Disease
Genetic Disorders
Others

Global Digital PCR Market Size by Application & CAGR (2026-2033)

Market Overview
Clinical Applications
Research Applications
Forensic Applications
Environmental Applications
Other Applications

Global Digital PCR Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals and Diagnostic Laboratories
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
CROs and CDMOs
Forensic Laboratories
Other End Users

Global Digital PCR Market Size & CAGR (2026-2033)

North America (Type, Product, Technology, Indication, Application, End User)
- US
- Canada
Europe (Type, Product, Technology, Indication, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Product, Technology, Indication, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Product, Technology, Indication, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Product, Technology, Indication, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Germany/Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JN Medsys Pte. Ltd. (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stilla Technologies SAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Standard BioTools Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avance Biosciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endress+Hauser Group Services AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eppendorf AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments